Screening
Screening for meningioma with magnetic resonance imaging (MRI, brain and spine, with and without contrast) is indicated in patients with neurofibromatosis 2 (NF2)-related schwannomatosis from age 10 onwards. MRI brain is recommended annually; MRI spine can be undertaken every 2 to 3 years.[47]
There is no evidence to support screening in other populations.
Use of this content is subject to our disclaimer